# Benralizumab (Genetical Recombination) S.C. Injection 10mg Syringe (ファセンラ皮下注１０ｍｇシリンジ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2290402G2027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2290402G2027
- **Product name (Japanese):** ファセンラ皮下注１０ｍｇシリンジ
- **English title:** Benralizumab (Genetical Recombination) S.C. Injection 10mg Syringe
- **Active ingredient:** ベンラリズマブ（遺伝子組換え）
- **Active ingredient (INN):** Benralizumab (Genetical Recombination)
- **Strength / unit:** １０ｍｇ０．５ｍＬ１筒
- **Route:** Injection (注射薬)
- **Therapeutic category:** 22 Respiratory agents (呼吸器官用薬) › 229 Other respiratory agents (その他の呼吸器官用薬)
- **Manufacturer:** AstraZeneca (アストラゼネカ)
- **NHI price (reference only):** JPY 134121 per １０ｍｇ０．５ｍＬ１筒
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2290402G2027
- **JSON:** https://www.nifujipharma.com/api/drugs/2290402G2027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Benralizumab%20(Genetical%20Recombination)%20S.C.%20Injection%2010mg%20Syringe%20(%E3%83%95%E3%82%A1%E3%82%BB%E3%83%B3%E3%83%A9%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%90%EF%BD%8D%EF%BD%87%E3%82%B7%E3%83%AA%E3%83%B3%E3%82%B8)%20%2F%20YJ%202290402G2027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Benralizumab (Genetical Recombination)

- [Benralizumab (Genetical Recombination) S.C. Injection 30mg Syringe (ファセンラ皮下注３０ｍｇシリンジ)](https://www.nifujipharma.com/drugs/2290402G1020) — ３０ｍｇ１ｍＬ１筒, AstraZeneca
- [Benralizumab (Genetical Recombination) S.C. Injection 30mg Pen (ファセンラ皮下注３０ｍｇペン)](https://www.nifujipharma.com/drugs/2290402G3023) — ３０ｍｇ１ｍＬ１キット, AstraZeneca